Paclitaxel-Coated Balloon Outperforms PTA in Superficial Fem
One-year results of the ILLUMENATE pivotal trial show that the investigational Stellarex™ drug-coated balloon (DCB) yields superior angiographic and clinical results compared with standard balloon angioplasty in a population with complex superficial femoral artery (SFA) disease.

“The ILLUMENATE pivotal trial met its 12-month primary safety and efficacy end points among one of the most complex patient populations studied in DCB investigational device exemption trials to date,” says co-principal investigator Sean Lyden, MD, who presented the findings at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C....